Sequence 459 from Patent EP2225397

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. [Oncogene. 2024]
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target.
Ferrari MG, Jimenez-Uribe AP, Wang L, Hoeppner LH, Murugan P, Hahm E, Yu J, Kuzel TM, Gradilone SA, Mansini AP. Oncogene. 2024 Feb; 43(7):484-494. Epub 2023 Dec 23.
Insights into the molecular basis and mechanism of heme-triggered TLR4 signalling: The role of heme-binding motifs in TLR4 and MD2. [Immunology. 2024]
Insights into the molecular basis and mechanism of heme-triggered TLR4 signalling: The role of heme-binding motifs in TLR4 and MD2.
Hopp MT, Holze J, Lauber F, Holtkamp L, Rathod DC, Miteva MA, Prestes EB, Geyer M, Manoury B, Merle NS, et al. Immunology. 2024 Feb; 171(2):181-197. Epub 2023 Oct 26.
Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy. [Immunology. 2022]
Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy.
Feldtmann R, Kümmel A, Chamling B, Strohbach A, Lehnert K, Gross S, Loerzer L, Riad A, Lindner D, Westermann D, et al. Immunology. 2022 Sep; 167(1):40-53. Epub 2022 Jun 29.

RefSeq alternative splicing
See 10 reference mRNA sequence splice variants for the LY96 gene.

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide